The clinical trial industry is stuck in an innovation impasse, weighed down by outdated processes, layers of bureaucracy, and a systemic inability to prioritize those on the frontlines - patients, sites, and researchers. Breaking Protocol, hosted by Tilda Research CEO Ram Yalamanchili, interviews clinical trial leaders at the cutting edge of innovation who are breaking past the current paradigm.